Quantcast

LOUISIANA RECORD

Thursday, April 18, 2024

Kayla Elder News


Pelican Institute: Voters need to elect legislators determined to make changes

By Kayla Elder |
The Pelican Institute for Public Policy's CEO called for a more impactful legislative session this fall and said it was up to the state's voters to demand change.

New legislature will determine success of civil justice reforms, Coalition for Common Sense argues

By Kayla Elder |
The Louisiana Coalition for Common Sense looks to new leadership this fall to advance civil justice reform.

Tensions run high in OK opioid trial Thursday; State focuses on risk data J&J relied on

By Kayla Elder |
NORMAN, Okla. (Legal Newsline) - Tensions ran high in court Thursday as the Oklahoma opioid trial continued, with defense attorney Larry Ottoway objecting throughout the day to opposing counsel's line of questioning directed at defense witness, business director for Janssen Pharmaceuticals Kimberly Deem-Eshleman.

Smaller crowd on hand second day of Oklahoma opioid trial; Father of OD victim testifies

By Kayla Elder |
NORMAN, Okla. (Legal Newsline) - Cleveland County District Judge Thad Balkman overruled several objections made by Johnson & Johnson/Janssen Pharmaceuticals (J&J) as the second day of trial unfolded in the state's pursuit of abatement in what it calls a man-made opioid crisis.

Hunter: Case is about abating 'worst' man-made crisis; J&J: Case is about damages - not abatement

By Kayla Elder |
NORMAN, Okla. (Legal Newsline) - Admitting there is a high potential for abuse in opioid medications, Johnson & Johnson attorney Larry Ottaway said during opening arguments on Tuesday that physicians prescribing its medications Nucynta and Duragesic know this risk and have to know it to be licensed.